Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

iRadimed Corporation - Common Stock (NQ:IRMD)

56.73 +0.13 (+0.24%)
Streaming Delayed Price Updated: 9:58 AM EDT, Jul 25, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,598
Open 55.11
Bid (Size) 56.10 (1)
Ask (Size) 57.39 (1)
Prev. Close 56.60
Today's Range 55.11 - 58.00
52wk Range 42.34 - 63.29
Shares Outstanding 12,673,441
Dividend Yield 1.20%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
IRADIMED CORP (NASDAQ:IRMD) – A Quality Stock Worth Considering
IRADIMED CORP (NASDAQ:IRMD) is a financially strong, debt-free company with high profitability and growth potential, making it a compelling choice for quality investors. 
Via Chartmill
IRadimed Corp (NASDAQ:IRMD) – A Quality Stock Worth Considering
IRadimed Corp (NASDAQ:IRMD) is a debt-free, high-ROIC medical device company with strong profitability and cash flow, making it a candidate for quality investors. 
Via Chartmill

Performance

YTD
+3.3%
+3.3%
1 Month
-6.2%
-6.2%
3 Month
+6.8%
+6.8%
6 Month
-6.0%
-6.0%
1 Year
+18.2%
+18.2%

More News

Read More
IRADIMED CORPORATION Announces FDA 510(k) Clearance for MRidium® 3870 Infusion Pump System
From iRadimed Corporation
Via GlobeNewswire
Why IRADIMED CORP (NASDAQ:IRMD) should be investigated by quality investors.
Via Chartmill
IRADIMED CORPORATION Announces First Quarter 2025 Financial Results
From iRadimed Corporation
Via GlobeNewswire
Earnings Scheduled For May 5, 2025
Via Benzinga
Earnings Scheduled For February 13, 2025
Via Benzinga
Should you consider IRADIMED CORP (NASDAQ:IRMD) for quality investing?
Via Chartmill
CORRECTION -- IRADIMED CORPORATION to Hold First Quarter of 2025 Financial Results Conference Call on May 5, 2025
From iRadimed Corporation
Via GlobeNewswire
IRADIMED CORPORATION to Hold First Quarter of 2025 Financial Results Conference Call on May 5, 2025
From iRadimed Corporation
Via GlobeNewswire
Intuitive Surgical Gets Rating Upgrade. No. 1 In Its Industry; Profits, Sales Climbing.
Via Investor's Business Daily
Topics Initial Public Offering
Exploring NASDAQ:IRMD's quality characteristics.
Via Chartmill
IRADIMED CORPORATION To Participate at the 37th Annual Roth Conference
From iRadimed Corporation
Via GlobeNewswire
IRADIMED CORPORATION Announces Fourth Quarter and Full Year of 2024 Financial Results and Increases its Regular Quarterly Cash Dividend to $0.17 Per Share from $0.15 Per Share
From iRadimed Corporation
Via GlobeNewswire
IRADIMED CORPORATION to Hold Fourth Quarter of 2024, Full Year of 2024 Financial Results Conference Call on February 13, 2025
From iRadimed Corporation
Via GlobeNewswire
Reasonable Growth, Debt Levels, and a High ROIC Make IRADIMED CORP (NASDAQ:IRMD) Appealing to Quality Investors.
Via Chartmill
IRADIMED CORPORATION Reports Preliminary Unaudited Record Fourth Quarter and Full-Year 2024 Revenues
From iRadimed Corporation
Via GlobeNewswire
IRADIMED CORPORATION to Present at the 43rd Annual J.P. Morgan Healthcare Conference
From iRadimed Corporation
Via GlobeNewswire
IRADIMED CORPORATION on Forbes’ List of America’s Most Successful Small-Cap Companies for 2025
From iRadimed Corporation
Via GlobeNewswire
IRADIMED CORPORATION Named to Fortune’s 100 Fastest Growing Companies List for 2024
From iRadimed Corporation
Via GlobeNewswire
IRADIMED CORPORATION Announces Third Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per Share
From iRadimed Corporation
Via GlobeNewswire
IRADIMED CORPORATION to Hold 2024 Third Quarter Financial Results Conference Call on October 31st
From iRadimed Corporation
Via GlobeNewswire
IRADIMED CORPORATION to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference
From iRadimed Corporation
Via GlobeNewswire
Masimo Stock Gets Relative Strength Rating Upgrade
Via Investor's Business Daily
Lytham Partners Announces KOL Panels and Participating Companies for its Fall 2024 Investor Conference
Via Newsfile

Frequently Asked Questions

Is iRadimed Corporation - Common Stock publicly traded?
Yes, iRadimed Corporation - Common Stock is publicly traded.
What exchange does iRadimed Corporation - Common Stock trade on?
iRadimed Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for iRadimed Corporation - Common Stock?
The ticker symbol for iRadimed Corporation - Common Stock is IRMD on the Nasdaq Stock Market
What is the current price of iRadimed Corporation - Common Stock?
The current price of iRadimed Corporation - Common Stock is 56.73
When was iRadimed Corporation - Common Stock last traded?
The last trade of iRadimed Corporation - Common Stock was at 07/25/25 09:58 AM ET
What is the market capitalization of iRadimed Corporation - Common Stock?
The market capitalization of iRadimed Corporation - Common Stock is 719.03M
How many shares of iRadimed Corporation - Common Stock are outstanding?
iRadimed Corporation - Common Stock has 719M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.